Literature DB >> 18974761

Neutrophil gelatinase-associated lipocalin suppresses cyst growth by Pkd1 null cells in vitro and in vivo.

Feng Wei1, Anil Karihaloo1, Vikas P Sukhatme1, Zhiheng Yu1, Arnaud Marlier1, Pankaj Seth2, Sekiya Shibazaki1, Tong Wang1, Stefan Somlo1, Lloyd G Cantley1.   

Abstract

Cyst growth in patients with autosomal dominant polycystic kidney disease is thought to be due to increased tubular cell proliferation. One model to explain this altered proliferation suggests that the polycystin proteins PC1 and PC2 localize to apical cilia and serve as an integral part of the flow-sensing pathway thus modulating the proliferative response. We measured proliferation and apoptosis in proximal tubule derived cell lines lacking PC1. These cells showed increased rates of proliferation, a decreased rate of apoptosis, compared to control heterozygous cell lines, and spontaneously formed cysts rather than tubules in an in vitro tubulogenesis assay. Addition of neutrophil gelatinase associated lipocalin (NGAL), a small secreted protein that binds diverse ligands, to the cells lacking PC1 inhibited proliferation and increased apoptosis leading to slower cyst growth in vitro. Sustained over-expression at low level of NGAL by an adenoviral delivery system suppressed cyst enlargement without improving renal function in the Pkd1 mutant mice. Our studies show that renal epithelial cells lacking PC1 have an inherent tendency to hyper-proliferate forming cysts in vitro independent of a flow stimulus. The potential benefit of attenuating cyst growth with NGAL remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18974761      PMCID: PMC3793389          DOI: 10.1038/ki.2008.395

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  58 in total

1.  Real-time quantitative RT-PCR after laser-assisted cell picking.

Authors:  L Fink; W Seeger; L Ermert; J Hänze; U Stahl; F Grimminger; W Kummer; R M Bohle
Journal:  Nat Med       Date:  1998-11       Impact factor: 53.440

2.  Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin.

Authors:  D H Goetz; S T Willie; R S Armen; T Bratt; N Borregaard; R K Strong
Journal:  Biochemistry       Date:  2000-02-29       Impact factor: 3.162

3.  Cardiac defects and renal failure in mice with targeted mutations in Pkd2.

Authors:  G Wu; G S Markowitz; L Li; V D D'Agati; S M Factor; L Geng; S Tibara; J Tuchman; Y Cai; J H Park; J van Adelsberg; H Hou; R Kucherlapati; W Edelmann; S Somlo
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

4.  The Caenorhabditis elegans autosomal dominant polycystic kidney disease gene homologs lov-1 and pkd-2 act in the same pathway.

Authors:  M M Barr; J DeModena; D Braun; C Q Nguyen; D H Hall; P W Sternberg
Journal:  Curr Biol       Date:  2001-09-04       Impact factor: 10.834

5.  The PKD1 gene product, "polycystin-1," is a tyrosine-phosphorylated protein that colocalizes with alpha2beta1-integrin in focal clusters in adherent renal epithelia.

Authors:  P D Wilson; L Geng; X Li; C R Burrow
Journal:  Lab Invest       Date:  1999-10       Impact factor: 5.662

6.  A human PKD1 transgene generates functional polycystin-1 in mice and is associated with a cystic phenotype.

Authors:  L Pritchard; J A Sloane-Stanley; J A Sharpe; R Aspinwall; W Lu; V Buckle; L Strmecki; D Walker; C J Ward; C E Alpers; J Zhou; W G Wood; P C Harris
Journal:  Hum Mol Genet       Date:  2000-11-01       Impact factor: 6.150

7.  The polycystin-1 C-terminal fragment triggers branching morphogenesis and migration of tubular kidney epithelial cells.

Authors:  Christian Nickel; Thomas Benzing; Lorenz Sellin; Peter Gerke; Anil Karihaloo; Zhen-Xiang Liu; Lloyd G Cantley; Gerd Walz
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

8.  Reduced Pax2 gene dosage increases apoptosis and slows the progression of renal cystic disease.

Authors:  L Ostrom; M J Tang; P Gruss; G R Dressler
Journal:  Dev Biol       Date:  2000-03-15       Impact factor: 3.582

9.  cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway.

Authors:  T Yamaguchi; J C Pelling; N T Ramaswamy; J W Eppler; D P Wallace; S Nagao; L A Rome; L P Sullivan; J J Grantham
Journal:  Kidney Int       Date:  2000-04       Impact factor: 10.612

10.  Polycystin-1, the gene product of PKD1, induces resistance to apoptosis and spontaneous tubulogenesis in MDCK cells.

Authors:  A Boletta; F Qian; L F Onuchic; A K Bhunia; B Phakdeekitcharoen; K Hanaoka; W Guggino; L Monaco; G G Germino
Journal:  Mol Cell       Date:  2000-11       Impact factor: 17.970

View more
  25 in total

1.  Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.

Authors:  Amandine Viau; Khalil El Karoui; Denise Laouari; Martine Burtin; Clément Nguyen; Kiyoshi Mori; Evangéline Pillebout; Thorsten Berger; Tak Wah Mak; Bertrand Knebelmann; Gérard Friedlander; Jonathan Barasch; Fabiola Terzi
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

2.  Smac-mimetic-induced epithelial cell death reduces the growth of renal cysts.

Authors:  Lucy X Fan; Xia Zhou; William E Sweeney; Darren P Wallace; Ellis D Avner; Jared J Grantham; Xiaogang Li
Journal:  J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 10.121

3.  Therapeutic targeting of BET bromodomain protein, Brd4, delays cyst growth in ADPKD.

Authors:  Xia Zhou; Lucy X Fan; Dorien J M Peters; Marie Trudel; James E Bradner; Xiaogang Li
Journal:  Hum Mol Genet       Date:  2015-04-15       Impact factor: 6.150

4.  A disintegrin and metalloprotease 10 activity sheds the ectodomain of the amyloid precursor-like protein 2 and regulates protein expression in proximal tubule cells.

Authors:  Rong Cong; Yuanli Li; Daniel Biemesderfer
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-16       Impact factor: 4.249

Review 5.  Olfactory Loss and Dysfunction in Ciliopathies: Molecular Mechanisms and Potential Therapies.

Authors:  Cedric R Uytingco; Warren W Green; Jeffrey R Martens
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

6.  Pharmacological reversal of renal cysts from secretion to absorption suggests a potential therapeutic strategy for managing autosomal dominant polycystic kidney disease.

Authors:  Murali K Yanda; Boyoung Cha; Cristina V Cebotaru; Liudmila Cebotaru
Journal:  J Biol Chem       Date:  2019-09-30       Impact factor: 5.157

7.  Macrophages promote cyst growth in polycystic kidney disease.

Authors:  Anil Karihaloo; Farrukh Koraishy; Sarah C Huen; Yashang Lee; David Merrick; Michael J Caplan; Stefan Somlo; Lloyd G Cantley
Journal:  J Am Soc Nephrol       Date:  2011-09-15       Impact factor: 10.121

8.  Urinary NGAL marks cystic disease in HIV-associated nephropathy.

Authors:  Neal Paragas; Thomas L Nickolas; Christina Wyatt; Catherine S Forster; Meghan Sise; Susan Morgello; Bernd Jagla; Charles Buchen; Peter Stella; Simone Sanna-Cherchi; Maria Luisa Carnevali; Silvia Mattei; Achiropita Bovino; Lucia Argentiero; Andrea Magnano; Prasad Devarajan; Kai M Schmidt-Ott; Landino Allegri; Paul Klotman; Vivette D'Agati; Ali G Gharavi; Jonathan Barasch
Journal:  J Am Soc Nephrol       Date:  2009-07-23       Impact factor: 10.121

9.  Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease.

Authors:  Xia Zhou; Lucy X Fan; William E Sweeney; John M Denu; Ellis D Avner; Xiaogang Li
Journal:  J Clin Invest       Date:  2013-06-17       Impact factor: 14.808

10.  Polycystin-1 regulates the stability and ubiquitination of transcription factor Jade-1.

Authors:  Rebecca L Foy; Vipul C Chitalia; Maria V Panchenko; Liling Zeng; Delia Lopez; Jean W Lee; Shaunak V Rana; Alessandra Boletta; Feng Qian; Leonidas Tsiokas; Klaus B Piontek; Gregory G Germino; Mina I Zhou; Herbert T Cohen
Journal:  Hum Mol Genet       Date:  2012-09-21       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.